Platform Formulation Development Utilizing a Novel Pulmonary Excipient and In Vivo Evaluation of Engineered Particles of Fluticasone Propionate as a Model Formulation

January 1, 2009

Vodak, D.T., D.E. Dobry, P.J. Kuehl, M. Doyle-Eisele, J.D. McDonald, A. Silcock, G. Magee, D. Pole, W.K. Miller, D.T. Friesen, and D.K. Lyon, “Platform Formulation Development Utilizing a Novel Pulmonary Excipient and In Vivo Evaluation of Engineered Particles of Fluticasone Propionate as a Model Formulation,” RDD Europe, 2(2009)251-254